These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2886066)

  • 21. Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
    De Cuyper H; Bollen J; van Praag HM; Verstraeten D
    Br J Psychiatry; 1986 May; 148():560-6. PubMed ID: 2877701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tardive dystonia--a case report on therapy and metaphylaxis].
    Genz A
    Psychiatr Neurol Med Psychol (Leipz); 1988 May; 40(5):264-8. PubMed ID: 2905065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis.
    Beresford R; Ward A
    Drugs; 1987 Jan; 33(1):31-49. PubMed ID: 3545764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute psychosis: in an emergency always still haloperidol?].
    Möller HJ
    Dtsch Med Wochenschr; 2008 Jan; 133(3):96. PubMed ID: 18186013
    [No Abstract]   [Full Text] [Related]  

  • 27. Depot bromperidol decanoate for schizophrenia.
    Wong D; Adams CE; David A; Quraishi SN
    Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating a psychotic woman with changing symptoms.
    Frances A; Mance RM
    Hosp Community Psychiatry; 1989 Sep; 40(9):905-7. PubMed ID: 2571556
    [No Abstract]   [Full Text] [Related]  

  • 29. High-dose treatment with neuroleptics in the acute phase of mental disease.
    Dencker SJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):32-4. PubMed ID: 14332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effective management of the acute psychotic patient: stabilization and maintenance with haloperidol].
    Garfinkel PE
    Acta Psiquiatr Psicol Am Lat; 1978 Dec; 24(4):297-301. PubMed ID: 36735
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rapid and megadose neuroleptic therapy. Critical review].
    de Girolamo G
    Minerva Psichiatr; 1985; 26(4):323-6. PubMed ID: 2869395
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute psychopharmacological management of the aggressive psychotic patient.
    Hughes DH
    Psychiatr Serv; 1999 Sep; 50(9):1135-7. PubMed ID: 10478897
    [No Abstract]   [Full Text] [Related]  

  • 33. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W; Boisvert D; Bradwejn J
    Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
    [No Abstract]   [Full Text] [Related]  

  • 34. Bromperidol decanoate (depot) for schizophrenia.
    Purgato M; Adams CE
    Cochrane Database Syst Rev; 2011 Sep; (9):CD001719. PubMed ID: 21901678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of depot neuroleptic haloperidol decanoate.
    Fernando J; Krishna Raju R; Jones GG; Stanley RO
    Acta Psychiatr Scand; 1984 Feb; 69(2):175-6. PubMed ID: 6702478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acutely psychotic patients: a treatment approach.
    Wagemaker H; Lippmann S; Cade JR
    South Med J; 1985 Jul; 78(7):833-7. PubMed ID: 2861662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.